Eyes and Vision | UT Southwestern Medical Center

MedBlog

Eyes and Vision

Aging; Eyes and Vision

Macular degeneration: Advances in stem cell and gene therapy

Rafael Ufret-Vincenty, M.D.

January 9, 2023

Latest

What to do if your child fails their school vision screening

November 29, 2022

Intra-arterial chemotherapy delivers most precise treatment for retinoblastoma

September 21, 2022

What's causing ‘electric’ facial pain? It might be trigeminal nerve damage

September 1, 2022

Ask the ophthalmologist: What causes floaters in the eye?

August 25, 2022

Understanding uveitis: A vision-threatening but treatable eye disease

July 28, 2022

Diabetic eye disease: How to spot the signs early

Type 2 diabetes can lead to eye damage and even blindness if left untreated. But 1 in 4 working-age adults have the disease and don't know it. In this week's MedBlog, ophthalmologist Yu-Guang He, M.D., discusses what patients need to know about diabetic eye disease. Learn more.

Yu-Guang He, M.D.

September 25, 2019

Eyes and Vision

Severe dry eye: Advanced solutions to a common, chronic condition

Health conditions such as Sjögren’s syndrome, rheumatoid arthritis, lupus, diabetes, and rosacea can cause severe dry eyes. Danielle Robertson, O.D., Ph.D., discusses our new Advanced Dry Eye Specialty Clinic designed for these patients and offers tips to help control dry eyes at home. Read more.

Danielle Robertson, O.D., Ph.D.

July 15, 2020

Eyes and Vision

New glaucoma therapies improve results and reduce recovery time

Gone are the days when people perceived glaucoma surgery to be as risky as the disease itself. Today’s patients can choose minimally invasive glaucoma surgeries (MIGS) or advanced medications for safe, effective treatment and quick recovery. Learn more.

October 10, 2018

Eyes and Vision

Ask the ophthalmologist: Will new eye drops really eliminate need for readers?

By age 40, millions of Americans begin dealing with age-related blurred vision when they read. New eye drops approved by the FDA recently help treat presbyopia, but are they a game-changer? UT Southwestern ophthalmologist William Waldrop, M.D. weighs in.

William Waldrop, M.D.

December 15, 2021

'Unlike some other vision disorders, keratoconus affects how light enters the eye and can distort how that light is interpreted by the brain. But CXL is actually a treatment to help strengthen the cornea to decrease or halt disease progression.'

Katrina Parker, O.D. and Steven Verity, M.D. quoted from: Corneal collagen cross-linking for keratoconus helps patients see better, longer

Eyes and Vision

See clearer – faster – with less-invasive cornea transplant surgery

It may take a year or more for full vision to return after a traditional cornea transplant, but a less-invasive method can have patients seeing clearly after only a few weeks or months. William Waldrop, M.D., explains.